Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513

Watchlist Manager
Chengdu Easton Biopharmaceuticals Co Ltd Logo
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Watchlist
Price: 32.5 CNY -5.93% Market Closed
Market Cap: 5.7B CNY
Have any thoughts about
Chengdu Easton Biopharmaceuticals Co Ltd?
Write Note

Relative Value

The Relative Value of one Chengdu Easton Biopharmaceuticals Co Ltd stock under the Base Case scenario is 52.72 CNY. Compared to the current market price of 32.5 CNY, Chengdu Easton Biopharmaceuticals Co Ltd is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
52.72 CNY
Undervaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
25
Median 3Y
5.5
Median 5Y
5.2
Industry
2.5
Forward
4
vs History
36
vs Industry
19
Median 3Y
25.6
Median 5Y
24.5
Industry
21.9
Forward
21
vs History
55
vs Industry
23
Median 3Y
31.1
Median 5Y
20.9
Industry
16.5
vs History
17
vs Industry
18
Median 3Y
-50.3
Median 5Y
-109.7
Industry
23.6
vs History
51
vs Industry
35
Median 3Y
2.5
Median 5Y
2.5
Industry
2.1
vs History
42
vs Industry
29
Median 3Y
4.4
Median 5Y
4.1
Industry
2.6
Forward
3.2
vs History
34
vs Industry
40
Median 3Y
5.5
Median 5Y
5.2
Industry
5.2
vs History
42
vs Industry
17
Median 3Y
23.3
Median 5Y
21.3
Industry
13.3
Forward
10.1
vs History
42
vs Industry
20
Median 3Y
23.3
Median 5Y
21.3
Industry
16.6
Forward
19.1
vs History
53
vs Industry
27
Median 3Y
25.3
Median 5Y
16.9
Industry
15.6
vs History
21
vs Industry
15
Median 3Y
-24.7
Median 5Y
-31.1
Industry
19.1
vs History
65
vs Industry
29
Median 3Y
3.4
Median 5Y
3.2
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Chengdu Easton Biopharmaceuticals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
5.7B CNY 4.9 23.7 20.3 20.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top